ランキング価格はじめての方へ
  1. 米国企業
  2. MOSAIC CO
  3. Raw

MOSAIC COMOS

時価総額
$76.7億
PER
濃縮リン酸塩とカリ肥料の生産販売の最大手。リン酸・カリ基盤の作物栄養剤、家畜用飼料原料、バイオ補助肥を展開。2024年12月に25%持分をMa'aden株111,012,433株との交換で約15億ドル相当で売却。北米・ブラジル・中国・インドなど約40カ国で展開。
概要財務
サマリーテーブルに戻る
2011年
5月31日		2012年
5月31日		2013年
5月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日		2024年
12月31日
Net earnings including noncontrolling interest2,5141,9311,8921,0301,002301-104470-1,0916661,6353,6141,209202
Depreciation, depletion and amortization4475086057517407116668848838488139349611,026
Deferred and other income taxes-197-246-200154-47183-612102261684-99-344261143
Equity in net (earnings) of nonconsolidated companies, net of dividends-84-32-5-28-33-34-13-65-9721923256
Asset Retirement Obligation, Accretion Expense32323342324026486268728296111
Debt Financing Fees, Amortization-------------37
Share-based compensation expense2123285441312828281830283332
Unrealized (gain) loss on derivatives21-461-35-3370-8-595927-7-429-104
Foreign Currency Transaction Loss, before Tax-------------463
Foreign Currency Transaction Gain (Loss), before Tax---------1436894-
(Gain) loss on sale of securities--23-18---2726-63-19-165-47-192
Pension Settlement------------42-42-
Gain (Loss) on Disposition of Business------------57-
Equity Method Investment, Realized Gain on Disposal-------------538
Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee-------------28
Other-8-12-11-47-18-8-18319--39-37-72
Receivables, net297-11829722761-391-6-35154684215-526-59
Inventories, net245-631613054-263156497-128-1911,068750-1,061276
Other current assets and noncurrent assets-242393-458313-24624-8736-661824723979
Accounts payable and accrued liabilities------244-66342-125333995220-1,05596
Other noncurrent liabilities-6066-161-1082461941-2190145-0108220
Net cash provided by operating activities2,4272,7061,888---9361,4101,0951,5832,1873,9362,4071,299
Capital expenditures1,2631,6391,5889291,0008438209551,2721,1711,2891,2471,4021,252
Purchases of available-for-sale securities - restricted-----1,6591,6765355586194347631,2411,530
Proceeds from Sale of Debt Securities, Available-for-Sale-----1,0291,6585195336074107431,2091,501
Proceeds from Sales of Business, Affiliate and Productive Assets------------158-
Payments to acquire businesses, gross---1,725---98555-24-41-
Other-4-7-511-7-20180-312-71-19
Net cash used in investing activities-572-1,627-1,590----668-1,945-1,361-1,189-1,322-1,260-1,317-1,261
Repayments of Other Short-term Debt---------1,5437271,7619,83216,780
Proceeds from Other Short-term Debt---------1,5211,0291,98110,00717,033
Repayments of inventory financing arrangement-----------1,6526011,805
Proceeds From Inventory Financing Arrangements-----------1,3496012,005
Payments of structured accounts payable arrangements----3967924197629771,1561,0281,4771,433755
Proceeds from Bank Debt----6354346678341,1241,0371,1231,4611,048737
Collections of transferred receivables----------4452,3521,469426
Payments of transferred receivables----------3642,4331,469426
Payments of long-term debt4705432260769102803486760861099567
Proceeds from Issuance of Long-term Debt18748281257201,25139-5--90070
Repurchases of stock-1,163-2,75571075--150-4111,665756235
Cash dividends paid89120427383385385211396776104198352271
Payments of Ordinary Dividends, Noncontrolling Interest----------31384232
Other-1-8-4844-1-5-1-6-613-26-32
Net cash used in financing activities-585-1,061-398---1,201-725-82-284-682-2,679-1,480-132
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations------------30-338
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect------1,483-1,323-33962192-32-393-56